title: [Advances in therapy and prevention of ischemic myocardial infarct].
abstract: In the acute stage of stroke, fibrinolytics are beneficial for up to 3, and in some patients up to 6, hours. If fibrinolytics are contraindicated, aspirin should be given. Heparin is dangerous due to the threat of intra- and extracranial hemorrhage. For secondary prevention, anticoagulants are indicated. When hypercholesterolemia is present, statins should be given.
authors.affiliation: Neurologische Universitätsklinik, Inselspital Bern.
authors.forename: H P
authors.initials: HP
authors.lastname: Mattle
mesh_terms: D001241:Aspirin / Q000008:administration & dosage / Q000009:adverse effects; D002544:Cerebral Infarction / Q000188:drug therapy* / Q000209:etiology / Q000517:prevention & control; D002986:Clinical Trials as Topic; D004347:Drug Interactions; D005343:Fibrinolytic Agents / Q000008:administration & dosage / Q000009:adverse effects; D006493:Heparin / Q000008:administration & dosage / Q000009:adverse effects; D006801:Humans; D012307:Risk Factors
chemical_list: D005343:Fibrinolytic Agents; D006493:Heparin; D001241:Aspirin